ARCHIVES

Phase III Study: Lymphoseek Superior to Vital Blue Dye

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

UC Breast Cancer ProgramTo Award $20 Million In Grants

December 16, 1994

NIGMS Hosts Meeting On Increasing Minorities In Biomedical Careers

December 1, 1995

New Staff Proposals For Comprehensive Center Recognition Considered By NCAB

January 19, 1979

Letter: A Modest Proposal To Abolish FDA

January 26, 1996

In Brief: Broder to Discuss Centers Plan Between Meeting; Symposium Depicted To William Scott

May 11, 1990

ODAC Recommends Iressa Approval As Third-Line Lung Cancer Treatment

September 27, 2002